Insider Selling: Privia Health Group (NASDAQ:PRVA) CFO Sells 600 Shares

Privia Health Group, Inc. (NASDAQ:PRVA) CFO David Mountcastle sold 600 shares of the stock in a transaction on Tuesday, July 7th. The shares were sold at an average price of $27.57, for a total value of $16,542.00. Following the completion of the sale, the chief financial officer owned 186,128 shares of the company’s stock, valued at $5,131,548.96. The trade was a 0.32% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

David Mountcastle also recently made the following trade(s):

• On Thursday, July 2nd, David Mountcastle sold 24,734 shares of Privia Health Group stock. The shares were sold at an average price of $27.50, for a total value of $680,185.00.
• On Friday, June 26th, David Mountcastle sold 17,196 shares of Privia Health Group stock. The shares were sold at an average price of $25.18, for a total value of $432,995.28.
• On Monday, May 11th, David Mountcastle sold 3,385 shares of Privia Health Group stock. The shares were sold at an average price of $22.60, for a total value of $76,501.00.
• On Monday, May 4th, David Mountcastle sold 1,206 shares of Privia Health Group stock. The stock was sold at an average price of $25.00, for a total value of $30,150.00.
• On Friday, May 1st, David Mountcastle sold 7,179 shares of Privia Health Group stock. The stock was sold at an average price of $25.03, for a total value of $179,690.37.

Privia Health Group Price Performance

Shares of Privia Health Group stock traded up $0.56 during midday trading on Thursday, reaching $27.77. The company had a trading volume of 1,133,894 shares, compared to its average volume of 940,108. The stock has a fifty day moving average price of $23.65 and a 200 day moving average price of $23.08. Privia Health Group, Inc. has a fifty-two week low of $18.77 and a fifty-two week high of $27.81. The firm has a market cap of $3.50 billion, a PE ratio of 173.57, a P/E/G ratio of 2.15 and a beta of 0.83.

Wall Street Analyst Weigh In

PRVA has been the topic of a number of recent analyst reports. Canaccord Genuity Group dropped their price target on shares of Privia Health Group from $35.00 to $34.00 and set a “buy” rating on the stock in a research report on Friday, May 8th. Barclays decreased their price objective on shares of Privia Health Group from $25.00 to $24.00 and set an “equal weight” rating for the company in a research report on Tuesday, May 26th. Zacks Research downgraded shares of Privia Health Group from a “hold” rating to a “strong sell” rating in a research note on Tuesday. Evercore set a $26.00 target price on shares of Privia Health Group in a report on Wednesday, April 8th. Finally, Weiss Ratings raised shares of Privia Health Group from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, July 2nd. Eleven analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, Privia Health Group has a consensus rating of “Moderate Buy” and an average price target of $31.15.

Institutional Investors Weigh In On Privia Health Group

A number of hedge funds have recently added to or reduced their stakes in the business. GAMMA Investing LLC boosted its holdings in shares of Privia Health Group by 14.0% during the 2nd quarter. GAMMA Investing LLC now owns 4,819 shares of the company’s stock worth $124,000 after buying an additional 592 shares in the last quarter. Harbor Investment Advisory LLC bought a new stake in shares of Privia Health Group in the 2nd quarter valued at $69,000. Central Pacific Bank Trust Division increased its stake in shares of Privia Health Group by 456.5% in the 2nd quarter. Central Pacific Bank Trust Division now owns 7,001 shares of the company’s stock valued at $180,000 after acquiring an additional 5,743 shares in the last quarter. Alpine Woods Capital Investors LLC acquired a new position in shares of Privia Health Group during the 1st quarter valued at $231,000. Finally, Edgestream Partners L.P. acquired a new position in shares of Privia Health Group during the 1st quarter valued at $2,847,000. 94.48% of the stock is currently owned by institutional investors.

About Privia Health Group

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.